Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC
暂无分享,去创建一个
J. Cave | I. Galea | C. Ottensmeier | T. Maishman | L. Stanton | S. Danson | E. Arriola | L. Nolan | C. Mulatero | T. Geldart | M. Wheater | R. Griffiths | N. Cross | V. Potter | D. Hamid | P. Woll